.jpg?format=webp&width=780)
Obesity is a major risk factor for severe disease in COVID‐19, with increased hospitalization, ICU admission and mortality. This increased impact of COVID‐19 in people with obesity (PWO) is likely driven, in part, by the well described obesity‐induced immune dysregulation. The present data indicate that PWO who survive COVID‐19 generate robust and durable SARS‐CoV‐2 specific T cell immunity that is equivalent to that seen in those without obesity.
Like
Save
Share